Thus, the overexpression of NR1D1 inhibited the tumorigenicity of bladder cancer cells, and NR1D1 played a role in cancer inhibition, implying it may be a new target for the treatment of bladder cancer. This evidence concerns the gene NR1D1 and urinary bladder carcinoma.